# Why Epitalon and Epithalamin Are Different Research Materials

- Article ID: research-102
- Product: Epitalon (epitalon-565)
- Canonical page: https://heritagebiolabs.com/research-library/articles/102-why-epitalon-and-epithalamin-are-different-research-materials
- Product collection: https://heritagebiolabs.com/research-library/products/epitalon
- Product page: https://heritagebiolabs.com/product/epitalon-565
- Reading focus: Study findings (Reading focus is a navigational tag, not an evidence grade.)
- Source years: 2003, 2026

> Educational article about published research. For research use only; not medical advice. Literature does not establish the identity, purity or activity of a purchased lot, and studies of individual components do not validate a blend.

A peptide is a short chain of amino acids linked by peptide bonds. A purified chain with a known sequence and a mixture extracted from tissue give researchers different materials to test. Epitalon, also spelled epithalon, is a defined four-amino-acid chain. Epithalamin is a pineal-derived peptide preparation. The names are similar and both appear in aging research, but knowing which one a study used is essential before attributing a finding to either. [1, 2]

An older human report by Khavinson and colleagues described observations in 266 older people who received different interventions involving pineal or thymic preparations. The authors reported differences in several clinical measures and mortality during follow-up. The pineal preparation they named was epithalamin. The report is cited for that material distinction, not as a clinical result for epitalon. Even a positive result with a mixture would not identify which molecule contributed to it, since the components may differ in their amounts and effects. [2]

The 2026 FDA briefing assessed the specific epitalon substances being considered. It found a different and limited set of reports involving human exposure to epitalon itself, including small studies of circadian markers. It did not identify clinical studies assessing the safety of the epitalon bulk substances. This contrast explains why looking up a familiar name and collecting every paper that uses a related name can make a body of evidence look more complete than it is. [1]

When reading a report, look for the full intervention name and whether the authors give a sequence or characterize an extract. Then check whether the measured result concerns one defined compound, a mixture or a combination with other care. Those details determine which study, if any, speaks to a claim about the peptide named on a label. [1, 2]

## Sources

1. US Food and Drug Administration. FDA Briefing Document for Epitalon-Related Bulk Drug Substances. Pharmacy Compounding Advisory Committee (2026-07-23). <https://www.fda.gov/media/193345/download>
2. Khavinson VKh et al. Peptides of pineal gland and thymus prolong human life. Neuro Endocrinology Letters (2003). <https://pubmed.ncbi.nlm.nih.gov/14523363/>

## Provenance

Article titles, body paragraphs and numbered citations extracted without rewriting from owner-supplied Word volumes. Product mappings use exact catalog labels; reading-focus tags and excerpts are navigational metadata. No independent peer-review or comprehensive source verification is claimed. Source volume: Peptide Research Articles 021 - Epitalon and Follistatin 315.docx; article 102; content SHA-256 3079e93f86b5cce790c1a0d95bd1b3107a5bfac4809056cd2aa686413341f3e7.
